Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.
Charles L. Vogel(Cancer Research Institute), Richard A. Gams(Breast Center), Irving Shemano, John R. Schoenfelder, D F Hayes
Cited by 123
Related Papers
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
|Journal of Clinical Oncology|1997|652
A common progenitor for human myeloid and lymphoid cells
|Nature|1978|277
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
|Journal of Clinical Oncology|1997|269
Lymphoblastic lymphoma: A clinicopathologic study of 95 patients
|Cancer|1981|175